Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

AstraZeneca, Biotech Partner on Messenger RNA Therapies

Global drug maker AstraZeneca is acquiring an option to license the rights to a technology based on genetic material transcribed from DNA, for new respiratory disease treatments. . . . → Read More: AstraZeneca, Biotech Partner on Messenger RNA Therapies

Peptide Immunotherapy Shown Safe for Type 1 Diabetes

In an early clinical trial, researchers in the U.K. show treatments with peptides, fragments of proteins, are safe and can slow the progression of type 1 diabetes. . . . → Read More: Peptide Immunotherapy Shown Safe for Type 1 Diabetes

University Spins Off Educational Robot Start-Up

A start-up enterprise spun-off from Harvard University is developing a learning system with robotics to teach computer coding to students. . . . → Read More: University Spins Off Educational Robot Start-Up

Trial to Test Inhaled Insulin, App for Diabetes Mgmt

A clinical trial is planned to test the benefits of managing type 2 diabetes with an inhaled formulation of insulin and a smartphone app. . . . → Read More: Trial to Test Inhaled Insulin, App for Diabetes Mgmt

Migraine Treatment Shown Effective in Late Trial

Results of a clinical trial show a single dose of new drug relieved migraine pain among more people with the condition, compared to a placebo. . . . → Read More: Migraine Treatment Shown Effective in Late Trial

Gene Editing, Therapy Company Gains $83.5M in Venture Funds

A biotechnology company designing treatments with gene edits and transfers using benign viruses is raising $83.5 million in its second venture funding round. . . . → Read More: Gene Editing, Therapy Company Gains $83.5M in Venture Funds

FDA Clears Algorithm-Assisted Cancer Diagnosis

The U.S. Food and Drug Administration cleared for marketing a diagnostics system aided by machine learning algorithms to help radiologists detect breast cancer. . . . → Read More: FDA Clears Algorithm-Assisted Cancer Diagnosis

Exosuit Shown to Improve Walking for Stroke Patients

A robotic device built and worn like clothing helps improve lower-limb walking performance for a group of people partially paralyzed with stroke. . . . → Read More: Exosuit Shown to Improve Walking for Stroke Patients

Lilly Licensing Autoimmune Therapy in $400M Deal

Drug maker Eli Lilly and Company is licensing a therapy from a biotechnology company that produces self-correcting cells for people with disorders caused by a malfunctioning immune system. . . . → Read More: Lilly Licensing Autoimmune Therapy in $400M Deal

Biotech Licensing Viral T-Cell Immunotherapies

A company making treatments for viral infections that stimulate natural T-cells in the immune system is licensing a related technology from Baylor College of Medicine. . . . → Read More: Biotech Licensing Viral T-Cell Immunotherapies